Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Host immunity contributes to the anti-melanoma activity of BRAF inhibitors.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Host immunity contributes to the anti-melanoma activity of BRAF inhibitors.
Host immunity contributes to the anti-melanoma activity of BRAF inhibitors. J Clin Invest. 2023 Dec 15; 133(24).
View in:
PubMed
authors with profiles
Richard Koya